The use of macrolide antibiotic substances in the treatment of asthma

Kaplan, 1959, The use of triacetyloleandomycin in chronic infectious asthma, 273 Fox, 1961, Infectious asthma treated with triacetyloleandomycin, Pennsylvania M. J, 64, 634 Goncharova, 1963, Stimulation of adrenal cortex by certain antibiotics of the macrolide group, 22, 953 Selenke, 1969, Glucocorticoid sparing effects of certain macrolide antibiotics, J. Allergy, 43, 156 Sorenson, 1957, Experimental toxicological studies on oleandomycin, Antibiotics & Chemother, 7, 419 Foltz, 1959, Oleandomycin—its derivatives and combinations—in the treatment of Staphylococcal infections, 39 Engel, 1963, Liver function studies in long-term triacetyloleandomycin therapy, Southern M. J, 56, 1279, 10.1097/00007611-196311000-00017 Weiner, 1962, Hepatic function in acne vulgaris patients treated with triacetylolendomycin: A preliminary report, New Drugs, 2, 307, 10.1177/009127006200200507 Robinson, 1962, Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate, Am. J. M. Sc, 243, 502, 10.1097/00000441-196204000-00012 Popper, 1959, Drug-induced hepatic injury, Ann. Int. Med, 51, 1230, 10.7326/0003-4819-51-6-1230 Sabath, 1968, Serum glutamic oxalacetic transaminase, New England J. Med, 279, 1137, 10.1056/NEJM196811212792104